An update during lunch? - April 25 FDA AdCom

April 25 - Day of FDA Advisory Committee MeetingПодробнее

When a Patient Speaks - Barbara BerneyПодробнее

Our response to the April 25th Advisory CommitteeПодробнее

Oral Testimony to the FDA Advisory Committee on the Approval of AMX0035Подробнее

April 24 - The day before FDA Advisory Committee MeetingПодробнее

FDA vaccine advisory committee meets Thursday for public reviewПодробнее

Why Approve Eteplirsen?Подробнее

PPMD's Pat Furlong | FDA Ad Comm Meeting for Eteplirsen April 25Подробнее

FDA advisory committee to discuss Pfizer COVID-19 vaccineПодробнее

FDA panel rejects drug that could combat rare terminal illnessПодробнее

FDA advisory committee meets soon to discuss authorizing boostersПодробнее

Abbreviated Response to the April 25th Advisory CommitteeПодробнее

The People's Health Briefing - 110221 - Week 44 - FDA advisory committee - Delta+ variantПодробнее

June 4, 2024 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)Подробнее

Our CEO, Dr. Ayguen Sahin, MSc, PhD's talk at FDA Advisory Committee Meeting - #EqualityInHealthcareПодробнее

FDA Advisory Committees Meet on Avandia SafetyПодробнее

FDA advisory committee set to decide whether booster shots are neededПодробнее

Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting (PSCP)Подробнее